OTC · AFIB
Healthcare · Medical - Devices
$0.00
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 1:02 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
AFIB does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning AFIB.
AFIB research
Company profile and research snapshot.
ACUTUS MEDICAL INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 16, 2022 | Goldman Sachs | Neutral | — |
| Jun 24, 2022 | BTIG | Buy | — |
| Apr 27, 2022 | BTIG | Buy | — |
| Apr 14, 2022 | Goldman Sachs | Neutral | — |
| Jan 20, 2022 | BTIG | Neutral | — |
No generated briefing is available yet.
defenseworld.net · Dec 7, 2025
Institutional and Insider Ownership 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AFIB.
No results
No recent SID articles mention AFIB.
